company background image
LIVEN logo

Liven Pharmaceuticals KASE:LIVEN Stock Report

Last Price

PK₨102.82

Market Cap

PK₨1.2b

7D

46.3%

1Y

542.6%

Updated

25 Dec, 2024

Data

Company Financials

Liven Pharmaceuticals Limited

KASE:LIVEN Stock Report

Market Cap: PK₨1.2b

My Notes

Capture your thoughts, links and company narrative

Liven Pharmaceuticals Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Liven Pharmaceuticals
Historical stock prices
Current Share PricePK₨102.82
52 Week HighPK₨102.93
52 Week LowPK₨9.11
Beta-0.017
1 Month Change79.66%
3 Month Change231.46%
1 Year Change542.63%
3 Year Change416.94%
5 Year Change795.64%
Change since IPO1,769.45%

Recent News & Updates

Recent updates

Shareholder Returns

LIVENPK PharmaceuticalsPK Market
7D46.3%-0.3%-2.5%
1Y542.6%181.7%63.7%

Return vs Industry: LIVEN exceeded the PK Pharmaceuticals industry which returned 181.7% over the past year.

Return vs Market: LIVEN exceeded the PK Market which returned 63.7% over the past year.

Price Volatility

Is LIVEN's price volatile compared to industry and market?
LIVEN volatility
LIVEN Average Weekly Movement14.1%
Pharmaceuticals Industry Average Movement7.1%
Market Average Movement7.2%
10% most volatile stocks in PK Market10.2%
10% least volatile stocks in PK Market4.8%

Stable Share Price: LIVEN's share price has been volatile over the past 3 months compared to the PK market.

Volatility Over Time: LIVEN's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of PK stocks.

About the Company

FoundedEmployeesCEOWebsite
20153Amin Hashwaniwww.liven-pharma.com

Liven Pharmaceuticals Limited manufactures and markets pharmaceutical products in Pakistan. The company was formerly known as Landmark Spinning Industries Limited and changed its name to Liven Pharmaceuticals Limited in November 2024. Liven Pharmaceuticals Limited was founded in 2015 and is based in Lahore, Pakistan.

Liven Pharmaceuticals Limited Fundamentals Summary

How do Liven Pharmaceuticals's earnings and revenue compare to its market cap?
LIVEN fundamental statistics
Market capPK₨1.25b
Earnings (TTM)PK₨139.96m
Revenue (TTM)PK₨88.91m

8.9x

P/E Ratio

14.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LIVEN income statement (TTM)
RevenuePK₨88.91m
Cost of RevenuePK₨64.10m
Gross ProfitPK₨24.81m
Other Expenses-PK₨115.15m
EarningsPK₨139.96m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)11.54
Gross Margin27.91%
Net Profit Margin157.42%
Debt/Equity Ratio2.1%

How did LIVEN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 20:40
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Liven Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution